Lobular breast carcinoma usually shows poor responsiveness to chemotherapies and often lacks targeted therapies. Since FGFR1 expression has been shown to play pivotal roles in primary breast cancer tumorigenesis, we sought to analyze the status of FGFR1 gene in a metastatic setting of lobular breast carcinoma, since promising FGFR1 inhibitors has been recently developed
Breast cancer, the main cancer in women, occurs in approximately 27% of all yearly diagnosed cancer ...
Background. Clinical trials based on FGFR mutation or amplification as a druggable target of FGFR in...
<div><p>Background and Aims</p><p>Amplification of the <i>fibroblast growth factor receptor 1</i> (<...
Background: Lobular breast carcinoma usually shows poor responsiveness to chemotherapies and often l...
Purpose: Classic lobular carcinomas (CLC) account for 10% to 15% of all breast cancers. At the genet...
Amplification of fibroblast growth factor receptor 1 (FGFR1) occurs in similar to 10% of breast canc...
The underlying mechanism of fibroblast growth factor receptor 1 (FGFR1) mediated carcinogenesis is s...
Invasive lobular carcinoma (ILC) is an understudied subtype of breast cancer that requires novel the...
Amplification of the fibroblast growth factor receptor 1 (FGFR1) is believed to predict response to ...
This is an open access article distributed under the terms of the Creative Commons Attribution Lice...
Fibroblast growth factors (FGFs) and their receptors (FGFRs) have been extensively investigated in s...
Introduction: Gene amplification is an important mechanism for activating oncogenes in malignant tum...
The fibroblast growth factor receptor (FGFR) cascade plays crucial roles in tumor cell proliferation...
FGFRL1 is a novel member of the FGF receptor family. It is expressed at very low levels in a great v...
Breast cancer (BC) is the most common malignancy and second only to lung cancer in terms of mortalit...
Breast cancer, the main cancer in women, occurs in approximately 27% of all yearly diagnosed cancer ...
Background. Clinical trials based on FGFR mutation or amplification as a druggable target of FGFR in...
<div><p>Background and Aims</p><p>Amplification of the <i>fibroblast growth factor receptor 1</i> (<...
Background: Lobular breast carcinoma usually shows poor responsiveness to chemotherapies and often l...
Purpose: Classic lobular carcinomas (CLC) account for 10% to 15% of all breast cancers. At the genet...
Amplification of fibroblast growth factor receptor 1 (FGFR1) occurs in similar to 10% of breast canc...
The underlying mechanism of fibroblast growth factor receptor 1 (FGFR1) mediated carcinogenesis is s...
Invasive lobular carcinoma (ILC) is an understudied subtype of breast cancer that requires novel the...
Amplification of the fibroblast growth factor receptor 1 (FGFR1) is believed to predict response to ...
This is an open access article distributed under the terms of the Creative Commons Attribution Lice...
Fibroblast growth factors (FGFs) and their receptors (FGFRs) have been extensively investigated in s...
Introduction: Gene amplification is an important mechanism for activating oncogenes in malignant tum...
The fibroblast growth factor receptor (FGFR) cascade plays crucial roles in tumor cell proliferation...
FGFRL1 is a novel member of the FGF receptor family. It is expressed at very low levels in a great v...
Breast cancer (BC) is the most common malignancy and second only to lung cancer in terms of mortalit...
Breast cancer, the main cancer in women, occurs in approximately 27% of all yearly diagnosed cancer ...
Background. Clinical trials based on FGFR mutation or amplification as a druggable target of FGFR in...
<div><p>Background and Aims</p><p>Amplification of the <i>fibroblast growth factor receptor 1</i> (<...